Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akaza

Showing results (11-20 of 293) with videos related to

Pageof 30
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2000
[Long-acting depot of LH-RH agonist]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[New direction of cancer hormonal therapy--concepts of this issue]H Akaza
BJU International|December 18, 2003
Adjuvant goserelin improves clinical disease-free survival and reduces disease-related mortality in patients with locally advanced or localized prostate cancerH Akaza
European Urology|January 1, 1995
BCG treatment of existing Ta, T1 tumours or carcinoma in situ of the bladderH Akaza
BJU International|November 4, 2004
Advanced prostate cancer treatment guidelines: a global perspective; trends of hormone therapy in JapanH Akaza
Progress in Clinical and Biological Research|January 1, 1988
Progress and controversies in chemotherapy of advanced unresectable and/or metastatic carcinoma of the bladderH Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1997
New strategy of bio-chemoprevention on recurrence of superficial bladder cancer based on a hypothesis of the mechanism of recurrenceH Akaza
International Journal of Urology : Official Journal of the Japanese Urological Association|January 1, 1997
Neurogenic bladder may be a side effect of focus resection in an epileptic patientN Sekido, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 5, 1999
[Progress in oral anti-cancer drug therapy for urological cancer]S Tsukamoto, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 11, 1998
[Recurrent urological cancer--diagnose and treatment]H Takeshima, H Akaza
Pageof 30

Showing results (11-20 of 293) with videos related to

Sort By:
Pageof 30
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2000
[Long-acting depot of LH-RH agonist]H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[New direction of cancer hormonal therapy--concepts of this issue]H Akaza
BJU International|December 18, 2003
Adjuvant goserelin improves clinical disease-free survival and reduces disease-related mortality in patients with locally advanced or localized prostate cancerH Akaza
European Urology|January 1, 1995
BCG treatment of existing Ta, T1 tumours or carcinoma in situ of the bladderH Akaza
BJU International|November 4, 2004
Advanced prostate cancer treatment guidelines: a global perspective; trends of hormone therapy in JapanH Akaza
Progress in Clinical and Biological Research|January 1, 1988
Progress and controversies in chemotherapy of advanced unresectable and/or metastatic carcinoma of the bladderH Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1997
New strategy of bio-chemoprevention on recurrence of superficial bladder cancer based on a hypothesis of the mechanism of recurrenceH Akaza
International Journal of Urology : Official Journal of the Japanese Urological Association|January 1, 1997
Neurogenic bladder may be a side effect of focus resection in an epileptic patientN Sekido, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 5, 1999
[Progress in oral anti-cancer drug therapy for urological cancer]S Tsukamoto, H Akaza
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 11, 1998
[Recurrent urological cancer--diagnose and treatment]H Takeshima, H Akaza
Pageof 30